Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Current Research in Translational Medicine|September 21, 2024
Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expressionIvetta Danylesko, Noga Shem-Tov, Ronit Yerushalmi, et al.
Experimental Hematology|March 24, 2007
Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphomaAvichai Shimoni, S Tzila Zwas, Yakov Oksman, et al.
Bone Marrow Transplantation|August 30, 2019
Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosisRoni Shouval, Yakov Vega, Joshua A Fein, et al.
British Journal of Haematology|October 29, 2021
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipientsNoga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, et al.
Leukemia & Lymphoma|May 13, 2006
Fertility status among women treated for aggressive non-Hodgkin's lymphomaAvishay Elis, Aharon Tevet, Ronit Yerushalmi, et al.
Leukemia|June 29, 2018
The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantationJoshua A Fein, Avichai Shimoni, Myriam Labopin, et al.
Bone Marrow Transplantation|June 30, 2021
High lactate dehydrogenase at time of admission for allogeneic hematopoietic transplantation associates to poor survival in acute myeloid leukemia and non-Hodgkin lymphomaMika Geva, Angharad Pryce, Roni Shouval, et al.
European Journal of Haematology|November 7, 2020
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemiaJonathan Canaani, Ivetta Danylesko, Noga Shemtov, et al.
Annals of Hematology|October 10, 2021
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective studyOren Pasvolsky, Shai Shimony, Ron Ram, et al.
Bone Marrow Transplantation|February 19, 2020
LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell transplantationRoni Shouval, Omer Teper, Joshua A Fein, et al.
Pageof 7